Category: Drugs

The resurgence of interest in traditional medicinal plants is revealing exciting possibilities in the fight against antibiotic resistant bacteria. Among

President Donald Trump’s recent executive order aims to expedite the approval process for psychedelic therapies, particularly those targeting mental

The recent actions by the FDA signal a pivotal shift in the landscape of psychedelic medicine, particularly with the expedited review of two notable

Ibogaine, a psychedelic compound derived from a shrub native to the Congo Basin, is garnering significant attention in the United States, particularly

The landscape of drug policy in the Republican Party is undergoing a significant transformation, marked by President Trump’s recent endorsement of

Federal health officials are embarking on a new initiative aimed at improving access to psychedelics for patients suffering from serious mental health

The Food and Drug Administration (FDA) is set to expedite its evaluation of several psychedelic drugs aimed at addressing mental health disorders. This

Recent research from the University of California, San Diego (UCSD) School of Medicine indicates a significant rise in the use of psilocybin, the active

The landscape of mental health treatment is undergoing a significant transformation, with psilocybin—a psychoactive compound found in “magic

Major Depressive Disorder (MDD) poses a significant challenge to global health, affecting millions and often leading to decreased quality of life.

The landscape of mental health treatment is undergoing a transformative shift as the U.S. Food and Drug Administration (FDA) moves to fast track the

OneSource Specialty Pharma Limited has made significant strides in the contract development and manufacturing organization (CDMO) sector. The company

Competitive Landscape in Obesity Treatments Eli Lilly’s recently introduced weight loss medication, Foundayo, has experienced a modest performance in its

Argentina’s National Administration of Drugs, Foods, and Medical Devices (Anmat) has made a significant decision to permanently revoke the operating

When it comes to protein consumption, the body undertakes an intricate process of breaking down proteins into their basic components—amino acids—which are

In the rapidly evolving landscape of biopharma, significant changes are on the horizon, particularly regarding the burgeoning field of psychedelics. With

Animal testing has long been a cornerstone of medical development, yet it remains a topic fraught with ethical dilemmas. The public often associates

In recent years, the complexity of drug development has escalated significantly. As the landscape evolves to include peptides, oligonucleotides, targeted

Recent viral footage from Bhayandar has reignited fears surrounding so called “zombie drugs” on social media. This phenomenon raises questions about the

The resurgence of interest in psychedelics, particularly psilocybin, is capturing public attention as scientific exploration advances. Magic mushrooms,

Kailera, a biotech company focused on obesity treatments, made headlines last month with its announcement of an initial public offering (IPO). The

Pharmacokinetics (PK) and pharmacodynamics (PD) are essential fields in pharmacy that delve into the intricacies of drug action within the human body.

Immutep Limited has made significant strides in the biotechnology sector, particularly with its recent achievement of Orphan Drug Designation from the

The vibrant nightlife that once thrived in places like the Hacienda now feels like a distant memory. An iconic venue that stood as the heart of the UK’s

The recent executive order from President Donald Trump has sparked renewed interest in the potential of psychedelics as treatments for various mental

The recent announcement by U.S. President Donald Trump to expedite the review process for psychedelic treatments has led to a significant uptick in the

Ibogaine, a psychoactive compound derived from the Tabernanthe iboga shrub native to Africa, is increasingly being recognized for its potential

On April 18, President Donald Trump introduced an executive order aimed at fast tracking the development of psychedelic substances for medical

Eli Lilly has made a significant move in the oncology landscape by agreeing to acquire Kelonia Therapeutics for a potential total of $7 billion. This

Stay updated with BioPharma Dive’s free newsletter, delivering the latest biopharma news directly to your inbox. BioAge’s Promising Inflammation Drug

WuXi AppTec has become a key player in the biotechnology industry, celebrating a remarkable 25 years of innovation and collaboration. Starting as a modest

Researchers at the University of Pennsylvania are pioneering a new approach to accelerate the development of RNA based drug delivery systems using

Samsung Biologics is enhancing its competitive edge in early drug development by presenting its organoid based drug discovery research at the prestigious

Network pharmacology represents a significant shift from traditional drug development strategies, which typically focus on single target interactions. By

Medicinal chemistry is a dynamic field focused on the design, optimization, and development of chemical compounds for pharmaceutical use. This discipline

The pursuit of small molecule drug discovery is a multifaceted endeavor aimed at developing chemical entities that meet specific target product profiles

A significant drug trafficking investigation has culminated in the arrest of 26 individuals connected to a vast narcotics operation spanning the Capital

Perris Man Faces Charges for Synthetic Drug Possession A 49 year old man has been charged with multiple offenses linked to the sale of fentanyl laced

Introduction In a significant development within the pharmaceutical sector, Eli Lilly has released updated safety data for its obesity medication,

Danaher Corporation has reported impressive first quarter results, exceeding profit forecasts primarily due to heightened demand for its bioprocessing

The landscape of multiple myeloma treatment is evolving, with GSK’s drug Blenrep gaining approval for broader use within the NHS in England. This

In our fast paced digital world, everyday annoyances can accumulate and become overwhelming. From unreliable internet connections to invasive advertising

Biologics represent a transformative force in healthcare, providing innovative therapies that range from fertility treatments to vaccines. Understanding

In the realm of new drug development, the efficiency of synthesizing a crucial chemical intermediate can determine the success or failure of a project.